What is NDC 35573-108?

35573-108 is the product NDC for Sodium Polystyrene Sulfonate, Sodium polystyrene sulfonate 15 g/60mL suspension, listed with the FDA by Burel Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Burel Pharmaceuticals, LLC, NDC labeler code 35573. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sodium Polystyrene Sulfonate?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sodium Polystyrene Sulfonate NDC 35573-108

NDC codes

FDA NDC Directory

Product NDC (as listed)35573-108Labeler and product segments. Claims need a package NDC.

Product NDC at billing width35573-0108Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
35573-108-14	3557301081435573010814	10 BOTTLE, UNIT-DOSE in 1 CARTON (35573-108-14) / 60 mL in 1 BOTTLE, UNIT-DOSE (35573-108-13)Marketed from Dec 18, 2025
35573-108-57	3557301085735573010857	473 mL in 1 BOTTLE (35573-108-57)Marketed from Jun 19, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Polystyrene Sulfonate
Generic name (nonproprietary): sodium polystyrene sulfonate
Active ingredients: Sodium polystyrene sulfonate — 15 g/60mL
Dosage form: Suspension
Route: Oral, Rectal
Labeler: Burel Pharmaceuticals, LLCNDC labeler code 35573
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214912
Marketing start: Dec 18, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 35573-108_609a9733-cc0e-48ed-b2e1-8d765a4650d7SPL ID 609a9733-cc0e-48ed-b2e1-8d765a4650d7SPL set ID 8bbeae67-a7ff-4fa6-b21e-fb8617cd9197RxCUI 313072UNII 1699G8679Z

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N435573010814 followed by a unit qualifier and the quantity

Package 35573-0108-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2025.

Indications (excerpt from the label)

INDICATION AND USAGE Sodium Polystyrene Sulfonate Suspension, USP is indicated for the treatment of hyperkalemia.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 35573-108

What is NDC 35573-108?: 35573-108 is the product NDC for Sodium Polystyrene Sulfonate, Sodium polystyrene sulfonate 15 g/60mL suspension, listed with the FDA by Burel Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sodium Polystyrene Sulfonate.
What is the active ingredient?: Sodium polystyrene sulfonate.
Who is the labeler?: Burel Pharmaceuticals, LLC, NDC labeler code 35573. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sodium Polystyrene Sulfonate?: 14 other product NDCs are listed under this name. See all Sodium Polystyrene Sulfonate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sodium Polystyrene Sulfonate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	SUNRISE PHARMACEUTICAL, INC.	11534-166	11534-0166-1511534-0166-1611534-0166-44
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-2390	63629-2390-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-8849	63629-8849-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	63629-8850	63629-8850-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	71335-2855	71335-2855-01
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Bryant Ranch Prepack	72162-1230	72162-1230-0272162-1230-07
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral	PuraCap Laboratories, LLC	24658-760	24658-0760-16
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral, Rectal	Chartwell RX, LLC	62135-340	62135-0340-1162135-0340-5362135-0340-62
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral	ATLANTIC BIOLOGICALS CORP.	17856-0024	17856-0024-0117856-0024-02
Sodium Polystyrene Sulfonate	Sodium polystyrene sulfonate 4.1 meq/g	Powder, For suspensionOral	Epic Pharma, LLC	42806-013	42806-0013-9442806-0013-96

All 15 Sodium Polystyrene Sulfonate NDCs